Notícias e Atividades da BioNano Genomics

BioNano Genomics é uma empresa listada sob o símbolo BNGO (US).

Veja o organograma con seus 21 executivos principais

Biografias mais buscadas da BioNano Genomics

• Albert Luderer, Interim Chief Executive Officer and Chairman of th...
• David Barker, Director
• Kristiina Vuori, Director

Recentes movimentos de executivos em BioNano Genomics

• Christopher Twomey antes Director, agora é Lead Independent Director  (Notícia publicada em 8 de maio de 2026).
• Albert Luderer antes Chairman of the Board, foi promovido a Interim President and Chief Executive Officer  (Notícia publicada em 8 de maio de 2026).

Criar um alerta
para seguir os movimentos de executivos da BioNano Genomics.

BioNano Genomics possui 2.405 concorrentes concorrentes Eurofins (Luxemburgo), Lonza (Suíça) e BioNTech (Alemanha).

Popular M&A news in Biotecnologia

• IMU Biosciences acaba de anunciar uma arrecadação de fundos de 53 milhões de dólares. (publicado em 3 de junho de 2026).
• NewLimit acaba de anunciar uma arrecadação de fundos de 435 milhões de dólares. (publicado em 3 de junho de 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (publicado em 1 de junho de 2026)..

Outros contatos sugeridos na indústria do Biotecnologia

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer da Inceptive
• Jan Van de Winkel - President and Chief Executive Officer da Genmab
• Valerie Hanote - Non-Executive Director da Eurofins

Saiba mais sobre a indústria do Biotecnologia

Últimos comunicados de imprensa de BioNano Genomics

• Bionano Announces Presentation of OGM Utility Across Key Research Applications at the Association for Molecular Pathology Annual Meeting | Bionano Genomics, Inc.
• Bionano Reports Third Quarter 2023 Results and Highlights Recent Business Progress | Bionano Genomics, Inc.
• Bionano Announces Presentation of OGM Utility Across Key Applications at the American Society of Human Genetics (ASHG) Annual Meeting | Bionano Genomics, Inc.
• Bionano to Report Third Quarter 2023 Financial Results and Host a Conference Call and Webcast on November 8, 2023 | Bionano Genomics, Inc.
• Thompson and Thompson Genetics and Genomics in Medicine Includes OGM in Latest Edition, Notes Workflow’s Performance and Ability to Detect More SVs than LRS at Lower Cost | Bionano Genomics, Inc.
• Bionano to Present at the 2023 Stifel Healthcare Conference | Bionano Genomics, Inc.
• Largest Study of Mendelian Disease Highlights how OGM, alongside other Techniques, May Enhance Success Rates in Identifying Molecular Causes of Genetic Disease | Bionano Genomics, Inc.
• Bionano Announces Peer-Reviewed Publication on the Utility of Combining OGM and WES for Evaluation of Pediatric Leukemia | Bionano Genomics, Inc.
• Bionano Announces Publication Demonstrating Utility of OGM as an Alternative to KT and CMA for Evaluating CRISPR-Edited Cells as Part of Stem Cell Therapy Development | Bionano Genomics, Inc.
• Bionano Announces Second OEM Partner has Received China NMPA Approval for DNA Extraction and Labeling Products for IVD Use of OGM in Reproductive Health | Bionano Genomics, Inc.
• View more press releases Close

Redes sociais sobre BioNano Genomics

• BioNano Genomics na Wikipedia, Google News e Yahoo Finance
• BioNano Genomics na LinkedIn, X (Twitter) e YouTube